Wisconsin Alumni Research Foundation
A Leader in University Technology Transfer since 1925
Home | Printer Friendly
Technologies
New Inventions
New Patents
Agriculture (144)
Analytical Instrumentation (129)
Cleantech (89)
Diagnostic Assays (61)
Drug Discovery (164)
Education & Training (9)
Engineering (12)
Engines & Power Electronics (54)
Food & Supplements (56)
Information Technology (120)
Materials & Chemicals (94)
Medical Devices (76)
Medical Imaging (125)
Micro & Nanotech (69)
Miscellaneous (2)
Pharmaceuticals & Vitamin D (209)
Plasma Processing (25)
Pluripotent Cells (23)
Culture
Differentiation
Fundamental technologies
Related technologies
Tools
Radiation Therapy (38)
Research Tools (287)
Semiconductors & Integrated Circuits (55)
Veterinary (20)
WARF: W03002US Pluripotent Cells
Method for Generating Primate Trophoblasts
INVENTORS James Thomson, Ren-He Xu
OVERVIEW
Embryonic stem cells are undifferentiated cells that can differentiate into a number of progenitor cell types. A trophoblast is a differentiated cell that is a precursor of the cells which participate in forming the human placenta. Trophoblast cells are difficult to isolate and are not readily available for research.
THE INVENTION
UW-Madison researchers have developed the first method to cause a culture of primate embryonic stem cells to repeatedly, directly and uniformly differentiate into trophoblast cells. Treating primate (non-human and human) embryonic stem cells with a single protein induction factor causes the cells to transform into trophoblast cells. Several protein factors, including bone morphogenic protein (BMP) 4, BMP2, BMP7 and growth and differentiation factor 5, can serve as trophoblast-induction factors. Trophoblast cells are created directly from embryonic stem cells without the intervening step of forming an embryoid body. This method results in a stable and nearly pure culture of primate trophoblast cells.
APPLICATIONS
  • Provides a reproducible and nearly inexhaustible supply of placental precursor cells
  • Useful for pharmaceutical investigations
  • May aid development of contraceptive drugs targeting embryo implantation
  • May aid development of therapeutics for preventing placenta-related birth defects
KEY BENEFITS
  • Enables the creation of cultures of nearly pure human trophoblasts in a uniform and reproducible manner
  • Trophoblast cells are stable and exhibit all the cellular characteristics of placental precursor cells.
ADDITIONAL INFORMATION
For More Information About the Inventors
Intellectual Property Status
Tech Fields
Pluripotent Cells - Differentiation
Drug Discovery - Stem cells
CONTACT INFORMATION
For current licensing status, please contact our team at licensing@warf.org or phone 608.262.4924. (Clicking this link will open a contact form in a popup window. If you have problems viewing the form, try disabling your popup blocker software.)
WARF Medal of Technology Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.


Contact Us | WARF Extranet | Privacy Policy | IMS Powered